Please login to the form below
AMD
This page shows the latest AMD news and features for those working in and with pharma, biotech and healthcare.
NHS wins legal fight with pharma over off-label Avastin
and Novartis’Lucentis to treat wet AMD, claiming that it broke EU and UK laws governing medicines licensing. ... CCGs across the country have been thwarted in their various attempts to introduce the cheaper but equally effective drug Avastin for the
Latest news
-
Bayer to challenge Avastin legal ruling
age-related macular degeneration (wet AMD) in place of two licensed but much more expensive treatments, Bayer’s Eylea and Novartis’Lucentis. ... The NHS in England spends around £500m on licensed wet AMD treatments, with around £300m being spent on
-
After Lucentis setback, Novartis trumpets data on follow-up drug
of Lucentis and Eylea for AMD, even though Avastin isn’t approved for the indication. ... Meanwhile, Eylea has been gaining ground in wet AMD thanks to less frequent dosing, accord to GlobalData.
-
Allergan’s abicipar matches AMD blockbuster Lucentis in phase III
Allergan’ s abicipar matches AMD blockbuster Lucentis in phase III. Bayer's Eylea remains the drug to beat, however. ... Allergan has positive phase III results for a wet age-related macular degeneration (AMD) drug that seems to be at least as good as
-
Joerg Moeller to head Bayer R&D after operational shake-up
The company has suffered a few R&D disappointments of late, however, including the failures of a Regeneron-partnered combination therapy for age-related macular degeneration (AMD) and a drug-device
-
Regeneron and Bayer drop AMD combination
Regeneron and Bayer drop AMD combination. Abandon plans after disappointing phase II trial results. ... advance the duo into phase III in either AMD or diabetic macular oedema.
More from news
Approximately 25 fully matching, plus 79 partially matching documents found.
Latest Intelligence
-
Deal Watch October 2018
Roche. RNA‐ targeted therapeutic, IONIS‐ FB‐ LRx targeting Factor. B, for Geographic Atrophy, an advanced form of dry Age-related Macular Degeneration (AMD). ... Effectively the deal is structured as an option, as the phase 2 study in dry AMD will
-
30 Women Leaders in UK Healthcare (part 2)
treatments for age-related macular degeneration (AMD).
-
The good, the bad and the ugly
In the EU, where there’s a high prevalence of AMD, Bayer has enjoyed great success with Eylea - growing revenues by 18% in 2017, ”says Alice Stevens, analyst, cardiovascular and metabolic ... The company plans to launch the highly anticipated
-
Working with our healthcare system more closely is vital
to essential treatment, expanding and improving care for people living with a leading cause of vision loss – age-related macular degeneration (AMD).
-
Deal Watch November 2015
The acquisition brings an ophthalmology focus with products for Stargardt's macular degeneration, dry AMD, and myopic macular degeneration. ... 380. Ocata Therapeutics. Astellas Pharma| Laurel. Acquisition - company. Regenerative medicine pipeline focus
More from intelligence
Approximately 0 fully matching, plus 11 partially matching documents found.
Latest appointments
-
Gyroscope Therapeutics appoints CEO
Gyroscope has a unique translational approach to tackling complex diseases such as dry AMD for which there are no therapies today.”.
More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.
Latest from PMHub
-
Remote Patient Monitoring Devices Market Great Impact In Near Future by 2026
Remote Patient Monitoring Devices Market: Key Players. Some of the key participating global remote patient monitoring devicesmarketare Hoffmann-La Roche Ltd., AMD Global Telemedicine, Honeywell International Inc., Omron Healthcare, Smiths Medical,
-
Global Dental Equipment & Consumables Market to Soar at a CAGR 6.1% to 2024: Growth Factors & Trends
Some of the notable industry players of global dental equipment &consumables market are A-Dec, AMD Lasers, BioLase, Carestream Dental, Danaher Corporation, Dentsply Sirona, Henry Schein, GC Orthodontics, Kerr Corp, Patterson
More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.
Featured jobs
-
Senior Medical Writer
-
Great salary and benefits
- Events Manager – Med Comms – Surrey
-
Salary TBC
-
New Business Director - PR
-
Competitive Salary and benefits
-
Account Director
-
Excellent benefits
- Account Manager / Senior Account Manager
-
35, 000-40, 000
-
SENIOR MEDICAL WRITER IN ONCOLOGY
-
Up to £60, 000.00 pension bonus
- Scientific Director / Editorial Team Leader
-
Great salary and benefits
-
Medical/ Scientific Director
-
Salary TBC
- Account Manager, Healthcare Public Affairs
-
£32, 000 – £40, 000 benefits
- Programme Director, Healthcare PR, Highly competitive package
-
Highly Competitive package
- Senior Account Director development role to Business Director, H...
-
Excellent package
-
Account Manager / Account Director
-
Competative
- Leadership opportunity, Pricing & Market Access, UK, Substan...
-
Substantial six figure package
- Account Manager, Healthcare Communications
-
£32, 000 - £40, 000 bonus benefits
- Senior Account Managers - Oxfordshire
-
Attractive salary and benefits package offered
-
Account Director
-
£48, 000 - £60, 000
Subscribe to our email news alerts
- Global Pain and Fever Relief Drugs Market Forecast to 2023 Industry Growth Drivers and Analysis Report
- Global Ovarian Cancer Treatment Drugs Market Forecast to 2023 Industry Growth Drivers and Analysis Report
- Mental Illness Drugs Market to Witness Growth Acceleration During 2018-2023
- Nuclear Medicine/Radiopharmaceuticals Market Set to Register 42.19 % CAGR to 2023
- Urinalysis Test Market Research Report Analysis and Forecasts to 2023
- Therapeutic Medical Guide Wire Market Overview, Growth Forecast, Demand and Development Research Report to 2023
PMHub
Complete HealthVizion
Complete HealthVizion is a global team of fresh thinkers who aspire to be better every day. We create life-changing medical...
Latest intelligence
- OUTiCO win Best in UK Pharmaceutical Outsourcing award
- The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
- Artificial Intelligence in Healthcare
- Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
- World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
- Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...
Quick links
Infographics
